caulfield12

https://www.yahoo.com/sports/white-sox-mvp-jos-abreu-010922346.html

Kolten Wong was a decent comp in terms of value. The type of player you really need, who isn't worth something like $8-9 million in arbitration to a mid-market team like the Cardinals but certainly provides a good value to those Top 10-12 teams payroll-wise who can afford to carry a salary like that. Ironic, is that the Brewer generally run an even tighter ship financially than the Cardinals. In that case, seemed they prioritized keeping the likes of Wainright and Molina in the fold.

Yes, only if you have one of those "generational" talents at that position, rather than roughly league average. Then giving an early extension really isn't worth it, especially without plus defense to go with it. If he's a Frank Thomas or even Abreu (granted, the middle part of his Sox career didn't live up to the first two years until 2020)...then you have to pursue it. Yes, pretty obvious observations. The problem, of course, is not knowing how close he's going to eventually end up to those two (now) historical Sox names.

Madrigal should be in that category with Kopech/Cease/Crochet where you see exactly where they are at performance and health-wise after this season is over. Any/all efforts should be directed at Giolito (seems unlikely) or Vaughn right now.

That said, look at where the Cubs are with their four "studs." Bryant and Baez have substantially diminished value. They could still get a really nice return for Contreras, but certainly not what it would have been from 2016-18. They got nothing out of Schwarber and Almora, and the Soler for Davis deal went the wrong way as well. Happ is pretty much the only prospect who's still remaining from those classes, unless you count Bote. Then they pretty much have to keep Rizzo and Hendricks to have at least two established Cubs' veterans to market.

Beckham Viciedo Marcus Semien (with White Sox) Brian Anderson Those are the main "busts" from the last decade plus. Rowand and Crede are about all we produced internally for almost a decade, and it took them a good 2-3 seasons to win the starting jobs. Of course, Joe Borchard comes to mind, but now we're going back almost 20 years.

J&J’s efficacy rate falls short compared to those of Pfizer (PFE) and Moderna (MRNA). Johnson and Johnson’s vaccine is 72% in preventing moderate-to-severe COVID-19 in the U.S., compared to Pfizer and Moderna’s efficacy rates of 95% and 94%, respectively, in preventing symptomatic disease. But don’t let the headline numbers discourage you, as it is not an apples-to-apples comparison. Johnson & Johnson’s vaccine was found to be 85% effective against severe COVID, similar to Moderna and Pfizer. ... Despite production delays, Johnson & Johnson does have an edge over Pfizer and Moderna when it comes to distribution. One big advantage is that Johnson & Johnson’s vaccine can be stored in a refrigerator for up to three months, compared to Pfizer and Moderna vaccines which must be stored at freezing temperatures. “I think it's incredible news for all of us… There are many advantages to a single-shot vaccine that can be stored in much warmer temperatures,” said Hathi. https://finance.yahoo.com/news/johnson-and-johnson-single-dose-vaccine-is-absolutely-a-game-changer-vaccinations-to-pick-up-171204467.html

No doubt the perception of J&J is a full 1/2 tier below.... minus the unique refrigeration conditions for the other two leaders in terms of efficacy. The J&J is closer to the roughly 70~80% effectiveness range?

I mean if Grandal or Eaton gets hurt... the composition changes dramatically without Vaughn up.

Vaughn was never likely to be traded in the first place with Abreu likely due for a decline over these next couple of seasons.

If you have Engel/Leury, Collins and Lucroy in the lineup... then you suddenly have a very meh offense.

https://www.yahoo.com/news/former-mlb-executive-says-albert-204137941.html Going after Pujols now about his age doesn't seem like a great look for the owners...do they actually believe the fans will side with them?

Let's just hope it doesn't get passed on to (Nick) Madrigal somehow...he might be the last you'd expect (which, in today's age, doesn't mean a thing.) That said, Callaway is one of those baseball archetypes (the cocky douchebag who hits on every "hottie" or "groupie" with two legs) that were quite common in the 1990's and are finally getting their comeuppance.

At least Cuomo, Newsom, and Whitmer (to a lesser extent) have been owned, amirite? Because the age of "political retribution" is seemingly with us as a permanent feature if it wasn't already beginning in the 1990's.

They were very competitive in 2013, but no playoffs...especially second half, they really ended the season on a high point and then carried it on into the following year. Two World Series in a row in 2014-15, then they REALLY spent a lot of money in 2016 and 2017. Too many injuries, Gordon fell off the map, etc. Let's not forget how the Yordano Ventura death set that franchise back, not unlike the Fernandez situation with the Marlins, he was always going to be their future ace and franchise pitcher. Not unlike our 2005/06 situation. They broke the franchise record for payrolls every year from 2013-2018, afaik.

Where the heck is Oscar Colas? Next signing class now?

What is the actual name of this brother? Video? When this was mentioned before, the only record of another brother that matched was living in Florida and in his early 20’s and seemed to have no connection to playing at all (it would be a bit of a coincidence for such a long Spanish name to match exactly, but not impossible.) There is only one sister in the family, that’s about the only thing one can verify online and through social media. 3-4 brothers. Unless they were brothers with different mothers, but not sure how likely that is either. https://www.nbcsports.com/chicago/white-sox/white-sox-rave-about-prospect-elijah-tatis-brother-fernando-tatis-jr They always mention Elijah as the younger brother...but not necessarily “the youngest.” Seems almost impossible to find any scouting reports or information about Daniel Fernando online. Fernando Tatis Jr. The son of Maria and Fernando Tatis Sr. His dad is a former 11-year MLB veteran infielder, widely known for hitting 2 grand slams in 1 inning on April 23, 1999 @ LAD (with STL) off Chan Ho Park... Has 3 brothers, Joshua, Elijiah and Daniel, and 1 sister, Maria. https://www.instagram.com/tatisdanielfernando/?hl=en So it’s Daniel Fernando Tatis. Two really short videos of him hitting. Definitely doesn’t have the height yet. https://celebs.infoseemedia.com/fernando-tatis-jr/fernando-tatis-jr-brother-daniel-fernando-tatis/ https://celebs.infoseemedia.com/fernando-tatis-jr/fernando-tatis-jr-sister-maria-fernanda-tatis/

Leury, 26 mlb homers in 1613 PA (about 10 if he played everyday) Engel, 21 in 1140 PA (about 11.5)

Social Capital Hedosophia Technology $600M Chamath Palihapitiya no Closed: Virgin Galactic 2017 Social Capital Hedosophia II Technology $360M Chamath Palihapitiya no Closed: Opendoor Technologies 2020 Social Capital Hedosophia III Technology $720M Chamath Palihapitiya no Closed: Clover Health 2020 Social Capital Hedosophia IV Technology $460M Chamath Palihapitiya no Seeking Target 2020 Social Capital Hedosophia IX Undisclosed Undisclosed Chamath Palihapitiya no Planning IPO 2021 Social Capital Hedosophia V Technology $805M Chamath Palihapitiya no Closing: SoFi Technologies 2020 Social Capital Hedosophia VI Technology $1.15B Chamath Palihapitiya no Seeking Target 2020 Social Capital Hedosophia VII Undisclosed Undisclosed Chamath Palihapitiya no Planning IPO 2021 Social Capital Hedosophia VIII Undisclosed Undisclosed Chamath Palihapitiya no Planning IPO 2021 Social Capital Hedosophia X Undisclosed Undisclosed Chamath Palihapitiya no Planning IPO 2021 Social Capital Hedosophia XI Undisclosed Undisclosed Chamath Palihapitiya no Planning IPO 2021 Social Capital Hedosophia XII Undisclosed Undisclosed Chamath Palihapitiya no Planning IPO 2021

One more year and it's too late. Then he's looking at $200-225 million on the open market...assuming a return to "normalized" revenues.

Vaughn has to be the last really obvious choice remaining...and that's mitigated somewhat by his positional limitation, although not much. After that, you've got guys like Cease, Madrigal and Kopech. Madrigal looks like a consistent bet to be an "above average" player, but he's certainly better managed on a year to year basis like Crede or Jenks because of that ongoing injury factor going back to Oregon State and his style of play. Most importantly, he's never going to break the bank in arbitration because his game isn't captured well by advanced stats or even HR's/RBI's/BB's.

If you believe he's willing to give a pitcher with one TJ surgery in his history $140-180 million...at the end of the 2023 season, he'll be 29, which is close to the ideal age for a pitcher hitting free agency. Obviously, 27 or 28 would be preferable, but that's as close to peak as you're going to get for a free agent pitcher. At the very best, you're going to buy out 1-2 years of free agency at this point...but that's becoming increasingly unlikely. Of course, if he has a disappointing season, you're unlikely to see the White Sox take the financial risk and Giolito's still going to bet on himself bouncing back in 2022/23.

There has always been an adjustment period, especially with someone who missed so much time in Cuba and after signing year...and also due to injuries. Look at Tim Anderson or Moncada or Jimenez. Heck, think how many years it took for Rowand or Crede to break the starting line-up. Robert has more talent than all of those guys (Moncada used to be considered right up there, and still could be)...but the first 2-3 years are always the toughest for anyone not named Mike Trout. Another player with a similar combination of talent/tools was Sammy Sosa, he started off pretty well his rookie year and then struggled to the point a change of scenery (or PED's) became necessary to reinvigorate his career.

Sure, it's a possibility. But has the same relative likelihood as Collins/Mercedes/Sheets at DH, or Leury Garcia as a starter.

You have Cease and Kopech to draw from, then our minor league depth, with Kelley the most likeliest. You'd be incredibly fortunate just to get one #2 starter out of Cease and Kopech, honestly. One has to assume that if Lynn repeats his last couple of seasons, he will go for the biggest possible extension available, and that won't be from the White Sox. Keuchel will be declining, and it's going to be at best a very IFFY proposition to move Crochet to a starting role, assuming they could get him to stop throwing at 100+ (or that he doesn't get injured coming out of the pen first). Now, we can relying on "lucking" into Keuchel for the 2020 season, but the odds over franchise history of the White Sox adding a #2 starter from outside the organization haven't been all that great (in terms of FA). Almost always, it has been success in the trade market (or rare "freebies" like Esteban Loiaza and later Jose Contreras.) They will need outside the box thinking, like a Scherzer/Greinke/Verlander type of move...or one of the numerous veterans that are heading into FA next year with Bottom 12-15 franchises that are in cost-cutting mode.